GlaxoSmithKline PLC (GSK) is investing in its Otriven range of nasal sprays this Spring with a sports-themed online campaign for Otri Allergie and a new xylometazoline and dexpanthenol combination version of Otriven Protect.
GSK’s new campaign for its Otri Allergie nasal spray suggests that German hay fever sufferers should keep
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?